Tvardi Therapeutics Stock Forecast - Naive Prediction
| TVRD Stock | 4.31 0.03 0.69% |
Tvardi Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Tvardi Therapeutics stock prices and determine the direction of Tvardi Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Tvardi Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the relative strength index (RSI) of Tvardi Therapeutics' share price is approaching 47. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Tvardi Therapeutics, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
EPS Estimate Current Year (1.90) | EPS Estimate Next Year (2.96) | Wall Street Target Price 56.2 |
Using Tvardi Therapeutics hype-based prediction, you can estimate the value of Tvardi Therapeutics from the perspective of Tvardi Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Tvardi Therapeutics using Tvardi Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Tvardi using crowd psychology based on the activity and movement of Tvardi Therapeutics' stock price.
Tvardi Therapeutics Short Interest
A significant increase or decrease in Tvardi Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Tvardi. Short interest can provide insight into the potential direction of Tvardi Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 16.9408 | Short Ratio 0.26 | Shares Short Prior Month 901.7 K | 50 Day MA 26.151 | Shares Short 632.6 K |
Tvardi Relative Strength Index
The Naive Prediction forecasted value of Tvardi Therapeutics on the next trading day is expected to be 4.28 with a mean absolute deviation of 0.14 and the sum of the absolute errors of 8.64.Tvardi Therapeutics Hype to Price Pattern
Investor biases related to Tvardi Therapeutics' public news can be used to forecast risks associated with an investment in Tvardi. The trend in average sentiment can be used to explain how an investor holding Tvardi can time the market purely based on public headlines and social activities around Tvardi Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Tvardi Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Tvardi Therapeutics.
Tvardi Therapeutics Implied Volatility | 1.0 |
Tvardi Therapeutics' implied volatility exposes the market's sentiment of Tvardi Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Tvardi Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Tvardi Therapeutics stock will not fluctuate a lot when Tvardi Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Tvardi Therapeutics on the next trading day is expected to be 4.28 with a mean absolute deviation of 0.14 and the sum of the absolute errors of 8.64. Tvardi Therapeutics after-hype prediction price | USD 4.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Tvardi Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Tvardi contract
Based on the Rule 16, the options market is currently suggesting that Tvardi Therapeutics will have an average daily up or down price movement of about 0.0625% per day over the life of the 2026-03-20 option contract. With Tvardi Therapeutics trading at USD 4.31, that is roughly USD 0.002694 . If you think that the market is fully incorporating Tvardi Therapeutics' daily price movement you should consider acquiring Tvardi Therapeutics options at the current volatility level of 1.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Tvardi Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Tvardi Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Tvardi Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Tvardi Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Tvardi Therapeutics' open interest, investors have to compare it to Tvardi Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Tvardi Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Tvardi. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Tvardi Therapeutics Additional Predictive Modules
Most predictive techniques to examine Tvardi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tvardi using various technical indicators. When you analyze Tvardi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Tvardi Therapeutics Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Tvardi Therapeutics' financial statements to predict how it will affect future prices.
Cash | First Reported 2010-12-31 | Previous Quarter 43.6 M | Current Value 28 M | Quarterly Volatility 6.5 M |
Tvardi Therapeutics Naive Prediction Price Forecast For the 29th of January
Given 90 days horizon, the Naive Prediction forecasted value of Tvardi Therapeutics on the next trading day is expected to be 4.28 with a mean absolute deviation of 0.14, mean absolute percentage error of 0.03, and the sum of the absolute errors of 8.64.Please note that although there have been many attempts to predict Tvardi Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Tvardi Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Tvardi Therapeutics Stock Forecast Pattern
| Backtest Tvardi Therapeutics | Tvardi Therapeutics Price Prediction | Buy or Sell Advice |
Tvardi Therapeutics Forecasted Value
In the context of forecasting Tvardi Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Tvardi Therapeutics' downside and upside margins for the forecasting period are 0.80 and 7.77, respectively. We have considered Tvardi Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Tvardi Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Tvardi Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.4054 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1394 |
| MAPE | Mean absolute percentage error | 0.0332 |
| SAE | Sum of the absolute errors | 8.6406 |
Predictive Modules for Tvardi Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tvardi Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tvardi Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Tvardi Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tvardi Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tvardi Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Tvardi Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Tvardi Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tvardi Therapeutics' historical news coverage. Tvardi Therapeutics' after-hype downside and upside margins for the prediction period are 0.84 and 7.78, respectively. We have considered Tvardi Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Tvardi Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of Tvardi Therapeutics is based on 3 months time horizon.
Tvardi Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Tvardi Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tvardi Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tvardi Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 3.49 | 0.00 | 0.01 | 31 Events / Month | 8 Events / Month | In about 31 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.31 | 4.31 | 0.00 |
|
Tvardi Therapeutics Hype Timeline
Tvardi Therapeutics is at this time traded for 4.31. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Tvardi is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.07%. %. The volatility of related hype on Tvardi Therapeutics is about 2423.61%, with the expected price after the next announcement by competition of 4.30. About 28.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.25. Tvardi Therapeutics had not issued any dividends in recent years. The entity had 1:3 split on the 16th of April 2025. Given the investment horizon of 90 days the next projected press release will be in about 31 days. Check out Historical Fundamental Analysis of Tvardi Therapeutics to cross-verify your projections.Tvardi Therapeutics Related Hype Analysis
Having access to credible news sources related to Tvardi Therapeutics' direct competition is more important than ever and may enhance your ability to predict Tvardi Therapeutics' future price movements. Getting to know how Tvardi Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tvardi Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CALC | CalciMedica Common Stock | 0.07 | 9 per month | 3.72 | 0.13 | 12.74 | (7.12) | 40.42 | |
| LTRN | Lantern Pharma | (0.13) | 8 per month | 0.00 | (0.05) | 10.27 | (5.57) | 23.91 | |
| LVTX | LAVA Therapeutics NV | (0.03) | 5 per month | 1.19 | 0.05 | 4.70 | (2.63) | 14.75 | |
| ATNM | Actinium Pharmaceuticals | 0.01 | 8 per month | 0.00 | (0.03) | 6.29 | (5.33) | 25.17 | |
| ELUT | Elutia Inc | (0.03) | 15 per month | 4.93 | 0.03 | 9.52 | (7.27) | 33.48 | |
| PDSB | PDS Biotechnology Corp | (0.03) | 8 per month | 4.55 | 0 | 8.60 | (8.41) | 27.78 | |
| RVPH | Reviva Pharmaceuticals Holdings | (0.01) | 8 per month | 0.00 | (0.02) | 10.71 | (12.50) | 75.31 | |
| XLO | Xilio Development | 0.05 | 22 per month | 0.00 | (0.11) | 4.69 | (5.56) | 15.41 | |
| TPST | Tempest Therapeutics | (0.27) | 7 per month | 0.00 | (0.17) | 7.92 | (9.56) | 57.69 | |
| FGEN | FibroGen | (1.07) | 7 per month | 0.00 | (0.07) | 4.33 | (5.28) | 28.75 |
Other Forecasting Options for Tvardi Therapeutics
For every potential investor in Tvardi, whether a beginner or expert, Tvardi Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Tvardi Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Tvardi. Basic forecasting techniques help filter out the noise by identifying Tvardi Therapeutics' price trends.Tvardi Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tvardi Therapeutics stock to make a market-neutral strategy. Peer analysis of Tvardi Therapeutics could also be used in its relative valuation, which is a method of valuing Tvardi Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Tvardi Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Tvardi Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tvardi Therapeutics shares will generate the highest return on investment. By undertsting and applying Tvardi Therapeutics stock market strength indicators, traders can identify Tvardi Therapeutics entry and exit signals to maximize returns.
Tvardi Therapeutics Risk Indicators
The analysis of Tvardi Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Tvardi Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting tvardi stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.6 | |||
| Standard Deviation | 3.4 | |||
| Variance | 11.55 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Tvardi Therapeutics
The number of cover stories for Tvardi Therapeutics depends on current market conditions and Tvardi Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Tvardi Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Tvardi Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Tvardi Therapeutics Short Properties
Tvardi Therapeutics' future price predictability will typically decrease when Tvardi Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Tvardi Therapeutics often depends not only on the future outlook of the potential Tvardi Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tvardi Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 M | |
| Cash And Short Term Investments | 37.9 M |
Check out Historical Fundamental Analysis of Tvardi Therapeutics to cross-verify your projections. For information on how to trade Tvardi Stock refer to our How to Trade Tvardi Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tvardi Therapeutics. If investors know Tvardi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tvardi Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.25) |
The market value of Tvardi Therapeutics is measured differently than its book value, which is the value of Tvardi that is recorded on the company's balance sheet. Investors also form their own opinion of Tvardi Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tvardi Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tvardi Therapeutics' market value can be influenced by many factors that don't directly affect Tvardi Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tvardi Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tvardi Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tvardi Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.